Gaelle Quereux
Advanced in Pemphigus Vulgaris

Gaelle Quereux

CHU De Clermont Ferrand
Clermont-ferrand, FR 
Advanced in Pemphigus Vulgaris
CHU De Clermont Ferrand
Clermont-ferrand, FR 
OverviewLocationsClinical Research

Overview

Gaelle Quereux practices in Clermont-ferrand, France. Ms. Quereux is rated as an Advanced expert by MediFind in the treatment of Pemphigus Vulgaris. Her top areas of expertise are Melanoma, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Pemphigus Vulgaris.

Her clinical research consists of co-authoring 149 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of Pemphigus Vulgaris.

Gender
Female

Locations

CHU de Clermont Ferrand
Clermont-ferrand, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Written Advice to Improve Compliance With Early Detection of Melanoma in First-degree Relatives: a Multicenter, Cluster-randomized Intervention Trial to Evaluate the Impact of Specific Incentives and Study Psychological Determinants of Early Melanoma Detection Behavior in First-degree Relatives
Written Advice to Improve Compliance With Early Detection of Melanoma in First-degree Relatives: a Multicenter, Cluster-randomized Intervention Trial to Evaluate the Impact of Specific Incentives and Study Psychological Determinants of Early Melanoma Detection Behavior in First-degree Relatives
Enrollment Status: Completed
Publish Date: May 15, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable

149 Total Publications

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.
Journal: Nature medicine
Published: September 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Quereux's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile